<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00552292</url>
  </required_header>
  <id_info>
    <org_study_id>25/1</org_study_id>
    <nct_id>NCT00552292</nct_id>
  </id_info>
  <brief_title>Complications in Hypertension and Obesity</brief_title>
  <official_title>National Investigation of Cardiovascular Complications in Arterial Hypertension and Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study in aimed to investigate epidemiology of risk factors in Russian Federation its
      prognostic value aimed on acceptance of national specific definition of metabolic syndrome
      and guidelines for its management.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>cardiovascular complications</measure>
    <time_frame>2007-2017</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>diabetes mellitus</measure>
    <time_frame>2007-2017</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">30000</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Hypertension</condition>
  <condition>Obesity</condition>
  <condition>Dyslipidemia</condition>
  <condition>Hyperglycemia</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, urine, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Age and sex-matched sample of subjects older 18 age
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age older 18 years

          -  Signed informed consent

          -  Blood pressure more than 130 and/or 85 mm Hg

          -  Waist circumference more than 80 sm in females and 94 in males and/or BMI more than 25
             kg/m2

          -  Dyslipidemia (elevated TG and/or decreased level of HDLP or therapy for high
             triglyceride level)

          -  Fasting glucose more than 5,6 mmol/l

        Exclusion Criteria:

          -  Associated clinical conditions (stroke, TIA, MI, heart failure, renal disease,
             diabetes mellitus)

          -  Severe concomitant diseases affecting outcome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eugene V Shlyakhto</last_name>
    <role>Study Director</role>
    <affiliation>Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexandra O Conrady, MD, PhD</last_name>
    <phone>+7812-70255-71</phone>
    <email>ahleague@mail.ru</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elena I Baranova, professor</last_name>
    <phone>346-9082</phone>
    <phone_ext>+7812</phone_ext>
    <email>eibaranova@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Almazov Federal Center of Heart, Blood and Endocrinology</name>
      <address>
        <city>St.Petersburg</city>
        <zip>194156</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oxana P Rotari, MD</last_name>
      <phone>7-812-7025556</phone>
      <email>rotariox@mail.ru</email>
    </contact>
    <investigator>
      <last_name>Oxana Rotari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2007</study_first_submitted>
  <study_first_submitted_qc>October 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2007</study_first_posted>
  <last_update_submitted>December 5, 2016</last_update_submitted>
  <last_update_submitted_qc>December 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health</investigator_affiliation>
    <investigator_full_name>Conrady Alexandra</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>metabolic syndrome</keyword>
  <keyword>hypertension</keyword>
  <keyword>obesity</keyword>
  <keyword>dyslipidemia</keyword>
  <keyword>hyperglycemia</keyword>
  <keyword>cardiovascular complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

